State Disclosure
Information for Prescribers of Prescription Drugs Provided Pursuant to Colorado HB 19-1131 and Connecticut HB 6669
RYPLAZIM® [factor x human]
| Marketed Prescription Drug | WAC* Price |
| RYPLAZIM | $2,495.85 |
Your patients’ out of pocket cost may be different
Below please find products considered in the same pharmaceutical therapeutic category**
None
Information on the variation efficacy of the legend (prescribed) drug marketed to different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document which can be accessed at https://www.kedrion.us/
*Wholesale Acquisition Cost (WAC) as published by Red Book represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to Red Book by the manufacturer. WAC does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price. Red Book does not perform any independent investigation or analysis of actual transaction prices for purposes of reporting WAC. Red Book relies on manufacturers to report or otherwise make available the values for the WAC.
For more information about Red Book’s drug pricing policy, visit
Https:www.micromedexsolutions.com
The USC (Uniform System of Classification) Therapeutic Classification schema was used to identify similar drug products. The HCFA Drug Category designation, as provided in the CMS (formerly HCFA) quarterly update, was used to determine the regulatory classification of the products. This list does not imply that the prescription drugs included are interchangeable or have equivalent efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
Source: RED BOOK 07/09/2025 as reprinted with permission from Merative Micromedex® Pharmaceutical Knowledge®. All rights reserved. ©2025
Information for Prescribers of Prescription Drugs Provided Pursuant to Colorado HB 19-1131 and Connecticut HB 6669
COAGADEX® [plasminogen, human-tvmh]
| Marketed Prescription Drug | WAC* Price |
| COAGADEX 250 IU | $11.89/IU |
| COAGADEX 500 IU | $11.89/IU |
Your patients’ out of pocket cost may be different
Below please find products considered in the same pharmaceutical therapeutic category**
None
Information on the variation efficacy of the legend (prescribed) drug marketed to different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document which can be accessed at https://www.kedrion.us/
*Wholesale Acquisition Cost (WAC) as published by Red Book represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to Red Book by the manufacturer. WAC does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price. Red Book does not perform any independent investigation or analysis of actual transaction prices for purposes of reporting WAC. Red Book relies on manufacturers to report or otherwise make available the values for the WAC.
For more information about Red Book’s drug pricing policy, visit
Https:www.micromedexsolutions.com
The USC (Uniform System of Classification) Therapeutic Classification schema was used to identify similar drug products. The HCFA Drug Category designation, as provided in the CMS (formerly HCFA) quarterly update, was used to determine the regulatory classification of the products. This list does not imply that the prescription drugs included are interchangeable or have equivalent efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
Source: RED BOOK 07/09/2025 as reprinted with permission from Merative Micromedex® Pharmaceutical Knowledge®. All rights reserved. ©2025
Information for Prescribers of Prescription Drugs Provided Pursuant to Colorado HB 19-1131 and Connecticut HB 6669
KOATE® [antihemophilic factor VIII human]
| Marketed Prescription Drug | WAC* Price |
| KOATE 250 IU | $1.44/IU |
| KOATE 500 IU | $1.44/IU |
| KOATE 1000 IU | $1.44/IU |
Your patients’ out of pocket cost may be different
Below please find products considered in the same pharmaceutical therapeutic category**
None
Information on the variation efficacy of the legend (prescribed) drug marketed to different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document which can be accessed at https://www.kedrion.us/
*Wholesale Acquisition Cost (WAC) as published by Red Book represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to Red Book by the manufacturer. WAC does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price. Red Book does not perform any independent investigation or analysis of actual transaction prices for purposes of reporting WAC. Red Book relies on manufacturers to report or otherwise make available the values for the WAC.
For more information about Red Book’s drug pricing policy, visit
Https:www.micromedexsolutions.com
The USC (Uniform System of Classification) Therapeutic Classification schema was used to identify similar drug products. The HCFA Drug Category designation, as provided in the CMS (formerly HCFA) quarterly update, was used to determine the regulatory classification of the products. This list does not imply that the prescription drugs included are interchangeable or have equivalent efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
Source: RED BOOK 07/09/2025 as reprinted with permission from Merative Micromedex® Pharmaceutical Knowledge®. All rights reserved. ©2025
Information for Prescribers of Prescription Drugs Provided Pursuant to Colorado HB 19-1131 and Connecticut HB 6669
KEDRAB® [rabies immune globulin]
| Marketed Prescription Drug | WAC* Price |
| KEDRAB 2 ml | $745.62 |
| KEDRAB 10 ml | $3,403.42 |
Your patients’ out of pocket cost may be different
Below please find products considered in the same pharmaceutical therapeutic category**
HYPERRAB 1 ml, 3 ml, and 5 ml
Information on the variation efficacy of the legend (prescribed) drug marketed to different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document which can be accessed at https://www.kedrion.us/
*Wholesale Acquisition Cost (WAC) as published by Red Book represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to Red Book by the manufacturer. WAC does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price. Red Book does not perform any independent investigation or analysis of actual transaction prices for purposes of reporting WAC. Red Book relies on manufacturers to report or otherwise make available the values for the WAC.
For more information about Red Book’s drug pricing policy, visit
Https:www.micromedexsolutions.com
The USC (Uniform System of Classification) Therapeutic Classification schema was used to identify similar drug products. The HCFA Drug Category designation, as provided in the CMS (formerly HCFA) quarterly update, was used to determine the regulatory classification of the products. This list does not imply that the prescription drugs included are interchangeable or have equivalent efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
Source: RED BOOK 07/09/2025 as reprinted with permission from Merative Micromedex® Pharmaceutical Knowledge®. All rights reserved. ©2025
Information for Prescribers of Prescription Drugs Provided Pursuant to Colorado HB 19-1131 and Connecticut HB 6669
RHOGAM® ULTRA-FILTERED PLUS [rho(d) immune globulin]
| Marketed Prescription Drug | WAC* Price |
| RHOGAM ULTRA-FILTERED PLUS ea | $123.00 |
| RHOGAM ULTRA-FILTERED PLUS 5s ea | $615.00 |
| RHOGAM ULTRA-FILTERED PLUS 25s ea | $3,075.00 |
Your patients’ out of pocket cost may be different
Below please find products considered in the same pharmaceutical therapeutic category**
HYPERRHO S/D ea ($82.83), 10s ea ($828.30), 10s ea Minidose ($298.30)
RHOPHYLAC 2 ml ($170.15), 2 ml 10s ($1,546.79)
Information on the variation efficacy of the legend (prescribed) drug marketed to different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document which can be accessed at https://www.kedrion.us/
*Wholesale Acquisition Cost (WAC) as published by Red Book represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to Red Book by the manufacturer. WAC does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price. Red Book does not perform any independent investigation or analysis of actual transaction prices for purposes of reporting WAC. Red Book relies on manufacturers to report or otherwise make available the values for the WAC.
For more information about Red Book’s drug pricing policy, visit
Https:www.micromedexsolutions.com
The USC (Uniform System of Classification) Therapeutic Classification schema was used to identify similar drug products. The HCFA Drug Category designation, as provided in the CMS (formerly HCFA) quarterly update, was used to determine the regulatory classification of the products. This list does not imply that the prescription drugs included are interchangeable or have equivalent efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
Source: RED BOOK 07/09/2025 as reprinted with permission from Merative Micromedex® Pharmaceutical Knowledge®. All rights reserved. ©2025
Information for Prescribers of Prescription Drugs Provided Pursuant to Colorado HB 19-1131 and Connecticut HB 6669
Albuked® [albumin human]/Kedbumin®[albumin human]/Albuminex®[albumin human]
| Marketed Prescription Drug | WAC* Price |
| Albuked 5 250 ml | $48.00 |
| Albuked 25 50 ml | $48.00 |
| Albuked 25 100 ml | $96.00 |
| Kedbumin 25% 50 ml | $48.00 |
| Kedbumin 25% 100 ml | $96.00 |
| Albuminex 5% 250 ml | $73.50 |
| Albuminex 5% 500 ml | $147.00 |
| Albuminex 25% 50 ml | $70.00 |
| Albuminex 25% 100 ml | $140.00 |
Your patients’ out of pocket cost may be different
Below please find products considered in the same pharmaceutical therapeutic category**
Albumin Human (Octapharma) 5%/25%, Albuminar-5/-25, ALBURX5%/25%, Albutein 5%/25%
Information on the variation efficacy of the legend (prescribed) drug marketed to different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document which can be accessed at https://www.kedrion.us/
*Wholesale Acquisition Cost (WAC) as published by Red Book represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to Red Book by the manufacturer. WAC does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price. Red Book does not perform any independent investigation or analysis of actual transaction prices for purposes of reporting WAC. Red Book relies on manufacturers to report or otherwise make available the values for the WAC.
For more information about Red Book’s drug pricing policy, visit
Https:www.micromedexsolutions.com
The USC (Uniform System of Classification) Therapeutic Classification schema was used to identify similar drug products. The HCFA Drug Category designation, as provided in the CMS (formerly HCFA) quarterly update, was used to determine the regulatory classification of the products. This list does not imply that the prescription drugs included are interchangeable or have equivalent efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
Source: RED BOOK 07/09/2025 as reprinted with permission from Merative Micromedex® Pharmaceutical Knowledge®. All rights reserved. ©2025
Information for Prescribers of Prescription Drugs Provided Pursuant to Colorado HB 19-1131 and Connecticut HB 6669
Gammaked® [immune globulin, human]
| Marketed Prescription Drug | WAC* Price |
| Gammaked 10% 10 ml | $215.86 |
| Gammaked 10% 25 ml | $344.24 |
| Gammaked 10% 50 ml | $1,079.32 |
| Gammaked 10% 100 ml | $2,158.62 |
| Gammaked 10% 200 ml | $4,317.26 |
Your patients’ out of pocket cost may be different
Below please find products considered in the same pharmaceutical therapeutic category**
See Gammaplex
Information on the variation efficacy of the legend (prescribed) drug marketed to different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document which can be accessed at https://www.kedrion.us/
*Wholesale Acquisition Cost (WAC) as published by Red Book represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to Red Book by the manufacturer. WAC does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price. Red Book does not perform any independent investigation or analysis of actual transaction prices for purposes of reporting WAC. Red Book relies on manufacturers to report or otherwise make available the values for the WAC.
For more information about Red Book’s drug pricing policy, visit
Https:www.micromedexsolutions.com
The USC (Uniform System of Classification) Therapeutic Classification schema was used to identify similar drug products. The HCFA Drug Category designation, as provided in the CMS (formerly HCFA) quarterly update, was used to determine the regulatory classification of the products. This list does not imply that the prescription drugs included are interchangeable or have equivalent efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
Source: RED BOOK 07/09/2025 as reprinted with permission from Merative Micromedex® Pharmaceutical Knowledge®. All rights reserved. ©2025
Information for Prescribers of Prescription Drugs Provided Pursuant to Colorado HB 19-1131 and Connecticut HB 6669
Gammaplex ® [Immune globulin, human]
| Marketed Prescription Drug | WAC* Price |
| Gammaplex 5% 100 ml | $1,116.32 |
| Gammaplex 5% 200 ml | $2,232.64 |
| Gammaplex 5% 400 ml | $4,465.29 |
| Gammaplex 10% 50 ml | $1.116.32 |
| Gammaplex 10% 100 ml | $2,232.64 |
| Gammaplex 10% 200 ml | $4,465.29 |
Your patients’ out of pocket cost may be different
Below please find products considered in the same pharmaceutical therapeutic category**
BIVIGAM, GAMMAGARD LIQUID, GAMMAGARD S/D, GAMUNEX-C, OCTAGAM, PANZYGA, PRIVIGEN, ALYGLO
Information on the variation efficacy of the legend (prescribed) drug marketed to different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document which can be accessed at https://www.kedrion.us/
*Wholesale Acquisition Cost (WAC) as published by Red Book represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to Red Book by the manufacturer. WAC does not represent actual transaction prices and does not include prompt pay or other discounts, rebates or reductions in price. Red Book does not perform any independent investigation or analysis of actual transaction prices for purposes of reporting WAC. Red Book relies on manufacturers to report or otherwise make available the values for the WAC.
For more information about Red Book’s drug pricing policy, visit
Https:www.micromedexsolutions.com
The USC (Uniform System of Classification) Therapeutic Classification schema was used to identify similar drug products. The HCFA Drug Category designation, as provided in the CMS (formerly HCFA) quarterly update, was used to determine the regulatory classification of the products. This list does not imply that the prescription drugs included are interchangeable or have equivalent efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
Source: RED BOOK 07/09/2025 as reprinted with permission from Merative Micromedex® Pharmaceutical Knowledge®. All rights reserved. ©2025